Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis
other
OA: bronze
public-domain-us
AI-generated summary
Women with endometriosis showed elevated pro-angiogenic factors that partially normalized in serum after surgical lesion removal.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To study the concentrations of vascular endothelial growth factor A (VEGF-A), soluble vascular endothelial growth factor receptors-1 and -2 (sVEGFR-1 and -2), angiogenin, and angiopoietin-2 (Ang-2) in serum and peritoneal fluid from healthy controls and women with advanced endometriosis. Further, we addressed the question of whether surgical removal of endometriotic lesions was associated with normalization of the serum concentrations of the same markers.
DESIGN: Patients with endometriosis before and after surgery were compared with control patients.
SETTING: University Hospital.
PATIENT(S): Twenty-one healthy controls and 32 women with advanced endometriosis.
INTERVENTION(S): In women with endometriosis we performed surgical removal of endometriotic lesions using laparoscopy.
MAIN OUTCOME MEASURE(S): Data on serum and peritoneal fluid concentrations of selected markers in healthy controls and women with endometriosis before surgery and in serum 5 to 7 days after surgery.
RESULT(S): Women with endometriosis had elevated levels of VEGF-A, sVEGFR-1, and Ang-2 in serum and all studied markers in peritoneal fluid compared with healthy controls. Surgical removal of endometriotic lesions resulted in decreased serum levels of pro-angiogenic VEGF-A and increased levels of sVEGFR-2 that negatively regulates the action of VEGF.
CONCLUSION(S): Women with advanced endometriosis have serum and peritoneal fluid concentrations of several factors involved in the regulation of angiogenesis that differ from those in healthy women, and these changes at least partly normalize within a week after surgical removal of the endometriotic lesions.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Funding
- funders
- [{'doi': '10.13039/100009656', 'name': 'Russian Academy of Medical Sciences', 'awards': []}, {'doi': '10.13039/501100004359', 'name': 'Vetenskapsrådet', 'awards': ['8683']}, {'doi': '10.13039/501100007687', 'name': 'Svenska Läkaresällskapet', 'awards': []}]
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (47)
- Angiogenic Factors in Endometriosis via crossref
- Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women via crossref
- Dating the Endometrial Biopsy via crossref
- Deeply Infiltrating Endometriosis: Implications, Diagnosis, and Management via crossref
- Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder via crossref
- Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis via crossref
- Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications via crossref
- Evaluation of serum and urinary angiogenic factors in patients with endometriosis via crossref
- Expression of heparanase and angiopoietin-2 in patients with endometriosis via crossref
- Higher activity by opaque endometriotic lesions than nonopaque lesions via crossref
- Is insulin resistance an essential component of PCOS?: The endometriosis syndromes: a clinical classification in the presence of aetiological confusion and therapeutic anarchy via crossref
- Laboratory testing for endometriosis via crossref
- Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis via crossref
- Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia via crossref
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via crossref
- Potential involvement of the immune system in the development of endometriosis via crossref
- Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia via crossref
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via crossref
- Serum Concentrations of Insulin‐like Growth Factor‐1, Soluble Tumor Necrosis Factor Receptor‐1 and Angiogenin in Endometriosis Patients via crossref
- Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis via crossref
- Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain via crossref
- Surgical Management of Deeply Infiltrating Endometriosis: An Update via crossref
- Theories of endometriosis via crossref
- The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions via crossref
- Urine vascular endothelial growth factor-A is not a useful marker for endometriosis via crossref
- Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum via crossref
- Vascular endothelial growth factor and endometriotic angiogenesis via crossref
- Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors via crossref
- Vascular endothelial growth factor and its soluble receptor in ovarian pathology via crossref
- Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis via crossref
- Vascular endothelial growth factor (VEGF) in endometriosis via crossref
- doi:10.1080/14767050701831397 via crossref
- doi:10.1001/archsurg.1920.01110020002001 via crossref
- doi:10.1023/a:1012245307884 via crossref
- doi:10.1097/01.aog.0000264552.85436.a1 via crossref
- doi:10.1021/bi00341a030 via crossref
- doi:10.1097/00006254-200008000-00024 via crossref
- doi:10.1126/science.277.5322.48 via crossref
- doi:10.1016/j.it.2006.10.004 via crossref
- doi:10.1124/jpet.105.086553 via crossref
- doi:10.1182/blood-2004-09-3531 via crossref
- doi:10.1006/bbrc.2000.3277 via crossref
- doi:10.1016/s0002-9440(10)64899-7 via crossref
- doi:10.1016/j.amjhyper.2005.03.745 via crossref
- doi:10.1272/jnms.74.223 via crossref
- doi:10.1007/s00464-007-9725-7 via crossref
- doi:10.1158/1541-7786.315.2.6 via crossref
Source provenance
- crossref
- last seen: 2026-05-17T01:00:06.560269+00:00
- europepmc
- last seen: 2026-08-21T06:14:13.963979+00:00
- pubmed
- last seen: 2026-05-13T22:14:11.755070+00:00
- unpaywall
- last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine